Endoluminal therapy for gastroesophageal reflux disease: Is the evidence for efficacy any stronger?

Thomas J. Lee*, Peter J. Kahrilas

*Corresponding author for this work

Research output: Contribution to journalReview article

4 Scopus citations


Gastroesophageal reflux disease is a common disorder often requiring chronic treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered US and European markets, claiming effectiveness comparable with antireflux surgery. Nevertheless, a paucity of data is available to support that efficacy, even as more devices are coming onto the market. This review examines published reports of endoluminal reflux therapies from January 2004 to January 2005. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments.

Original languageEnglish (US)
Pages (from-to)202-206
Number of pages5
JournalCurrent gastroenterology reports
Issue number3
Publication statusPublished - Jun 2005


ASJC Scopus subject areas

  • Gastroenterology

Cite this